Cost and cost-effectiveness of point-of-care testing and treatment for sexually transmitted and genital infections in pregnancy in low-income and middle-income countries: a systematic review protocol
- PMID: 31727649
- PMCID: PMC6887066
- DOI: 10.1136/bmjopen-2019-029945
Cost and cost-effectiveness of point-of-care testing and treatment for sexually transmitted and genital infections in pregnancy in low-income and middle-income countries: a systematic review protocol
Abstract
Introduction: The economic and health burden of sexually transmitted and genital infections (henceforth, STIs) in low-income and middle-income countries (LMICs) is substantial. Left untreated, STIs during pregnancy may result in several adverse pregnancy and birth outcomes. Timely diagnosis and treatment at point-of-care (POC) can potentially improve these outcomes. Despite the availability and promotion of POC diagnostics for STIs as a key component of antenatal care in LMICs, their widespread use has been limited, owing to the high economic costs faced by individuals and health systems. To date, there have been no systematic reviews which explore the cost or cost-effectiveness of POC testing and treatment of STIs in pregnancy in LMICs. The objective of this protocol is to outline the methods that will compare, synthesise and appraise the existing literature in this domain.
Methods and analysis: We will conduct literature searches in MEDLINE, Embase and Web of Science. To find additional literature, we will search Google Scholar and hand search reference lists of included papers. Two reviewers will independently search databases, screen titles, abstracts and full texts; when necessary a third reviewer will resolve disputes. Only cost and cost-effectiveness studies of POC testing and treatment of STIs, including syphilis, chlamydia, trichomonas, gonorrhoea and bacterial vaginosis, in pregnancy in LMICs will be included. Published checklists will be used to assess quality of reporting practices and methodological approaches. We will also assess risk of publication bias. Interstudy heterogeneity will be assessed and depending on variation between studies, a meta-analysis or narrative synthesis will be conducted.
Ethics and dissemination: Ethical approval is not required as the review will use published literature. The results will be published in a peer-reviewed open source journal and presented at an international conference.
Prospero registration number: CRD42018109072.
Keywords: cost-effectiveness; costs; genital infections; point-of-care; pregnancy; sexually transmitted infections.
© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Figures
Similar articles
-
Point-of-care testing and treatment of sexually transmitted and genital infections during pregnancy in Papua New Guinea (WANTAIM trial): protocol for an economic evaluation alongside a cluster-randomised trial.BMJ Open. 2021 Aug 12;11(8):e046308. doi: 10.1136/bmjopen-2020-046308. BMJ Open. 2021. PMID: 34385236 Free PMC article.
-
Economic evaluation of point-of-care testing and treatment for sexually transmitted and genital infections in pregnancy in low- and middle-income countries: A systematic review.PLoS One. 2021 Jun 17;16(6):e0253135. doi: 10.1371/journal.pone.0253135. eCollection 2021. PLoS One. 2021. PMID: 34138932 Free PMC article.
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
Facilitators and barriers to point-of-care testing for sexually transmitted infections in low- and middle-income countries: a scoping review.BMC Infect Dis. 2022 Jun 20;22(1):561. doi: 10.1186/s12879-022-07534-9. BMC Infect Dis. 2022. PMID: 35725437 Free PMC article.
-
Shifting the power: scale-up of access to point-of-care and self-testing for sexually transmitted infections in low-income and middle-income settings.Curr Opin Infect Dis. 2023 Feb 1;36(1):49-56. doi: 10.1097/QCO.0000000000000895. Curr Opin Infect Dis. 2023. PMID: 36753705 Review.
Cited by
-
Associations of toluidine red unheated serum test response to the treatment of syphilis in pregnancy and congenital syphilis: a 10-year real-world study.Chin Med J (Engl). 2022 Jul 25;135(13):1563-9. doi: 10.1097/CM9.0000000000002115. Online ahead of print. Chin Med J (Engl). 2022. PMID: 35830212 Free PMC article.
-
Advantages of Syndromic Diagnostics: Detection of the Pathogens Causing Urethritis/Cervicitis with the STI CNM Real-Time PCR Kit from Vitro S.A.Pol J Microbiol. 2024 Dec 13;73(4):529-534. doi: 10.33073/pjm-2024-045. eCollection 2024 Dec 1. Pol J Microbiol. 2024. PMID: 39670640 Free PMC article.
-
Treatment evaluation to improve preventing mother to child transmission among women with syphilis.Sci Rep. 2019 Dec 20;9(1):19547. doi: 10.1038/s41598-019-56095-6. Sci Rep. 2019. PMID: 31862938 Free PMC article.
-
Lactobacillus rhamnosus and Lactobacillus casei Affect Various Stages of Gardnerella Species Biofilm Formation.Front Cell Infect Microbiol. 2021 Feb 19;11:568178. doi: 10.3389/fcimb.2021.568178. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 33680986 Free PMC article.
-
Point-of-care testing and treatment of sexually transmitted and genital infections during pregnancy in Papua New Guinea (WANTAIM trial): protocol for an economic evaluation alongside a cluster-randomised trial.BMJ Open. 2021 Aug 12;11(8):e046308. doi: 10.1136/bmjopen-2020-046308. BMJ Open. 2021. PMID: 34385236 Free PMC article.
References
-
- WHO Sexually transmitted infections (STIs): the importance of a renewed commitment to STI prevention and control in achieving global sexual and reproductive health. Geneva, Switzerland: WHO, 2012: 8.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical